A Southern California-based maker of devices designed to treat blood vessel diseases plans to close a Silicon Valley plant this spring, but it is doubling down on its sizable production facility near Sonoma County airport.
Endologix LLC, which came to Santa Rosa 10 years ago in a $211 million deal with stent maker TriVascular Technologies, intends to close its Milpitas facility and lay off 31 workers there between May 6 and June 12, according to Worker Adjustment and Retraining Notification (WARN) Act notices submitted March 5.
The company told the Journal Friday, March 13 that Milpitas operations will end May 6, shifting to Santa Rosa.
“This transition has been thoughtfully planned over time and we are committed to managing the closure with transparency and care. We have kept our employees informed of our intentions to close this site, sharing updates as recently as last month,” the statement said.
That will leave the company with two production locations: nearly 110,000 square feet at 3910 Brickway Blvd. north of Santa Rosa and about 129,000 square feet in Irvine. TriVascular had moved into the Santa Rosa building in 2005.
Endologix acquired the Milpitas site when it picked up PQ Bypass in April 2021. That was about six months after health care private-equity funder Deerfield Management acquired Endologix out of Chapter 11 reorganization and took the then publicly traded company private. Endologix had sought bankruptcy protection in mid-2020 with over $260 million in debt. Deerfield had invested in Endologix in 2017 and PQ Bypass a year later.
The company’s commercial products are led by AFX2 endovascular system for abdominal aortic aneurysms, Alto abdominal stent grafts, and the Detour system PQ Bypass designed to treat a range of vascular diseases from abdominal aortic aneurysms to lower-limb peripheral vascular disease.
TriVascular started in Sonoma County in 1998 and grew to 270 employees when Boston Scientific shut it down in mid-2006, a year after it acquired the company. Founders and investors reopened in early 2008 then went public in April 2014.
Jeff Quackenbush joined North Bay Business Journal in May 1999. He covers primarily wine, construction and real estate. Reach him at jeff@nbbj.news or 707-521-4256.